Drug Patent Watch

DECEMBER 10, 2024

This article delves into India’s growing importance in generic drug API manufacturing, highlighting the key factors contributing to its success and the challenges it faces. 2024, February 27). Retrieved from [link] Califf, R. 2023, October 25). ” Retrieved from [link] Maersk. Retrieved from [link] Invest India.

Pharmaceutical Manufacturing

Pharmaceutical Technology

JUNE 9, 2025

In this article, GlobalData investigates key reimbursement trends that reflect the current delays to patient access across the European region. On average, 58% of branded drugs approved between 2021 and 2024 in Europe have either fully or restricted reimbursement. Credit: New Africa via Shutterstock.

Communication

PharmaVoice

JULY 21, 2025

Published July 21, 2025 By Kelly Bilodeau post share post print email license Mario Tama via Getty Images Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback.

Biosimilars

Fuld & Company Blog

AUGUST 20, 2024

How would you assess the deal activity for H1 2024? In the first half of 2024, we have seen some promising signs in tech M&A activity. Do you think a single rate cut could have a meaningful impact on lower middle market deal activity in 2024? Is the market finally picking up? in 2021 to $850B in 2023 according to PWC.

Documentation

Pharmaceutical Commerce

JUNE 17, 2025

The opinions expressed in this article are those of the author and do not necessarily reflect the views, policies, or positions of Otsuka America Pharmaceutical, Inc. She is currently the executive director of the Otsuka Patient Assistance Foundation, Inc. or the Otsuka Patient Assistance Foundation, Inc. Related Content Policy Whiplash?

Pharmaceutical Companies

European Pharmaceutical Review

DECEMBER 4, 2024

Article: Life sciences response to 2024 Autumn Budget The post Restoring regulatory excellence “central” to UK life science competitiveness appeared first on European Pharmaceutical Review.

Communication

The Guardian - Pharmaceutical Industry

MAY 25, 2025

Plus a letter from Barbara Richardson Your article ( Im taking beta blockers for my anxiety and so are many of my friends. In October 2024, the General Pharmaceutical Council published advice for pharmacy professionals also highlighting the risk of toxicity. Is that a problem?,

European Pharmaceutical Review

AUGUST 7, 2025

This article traces the compliance journey, from initial industry responses to the AI Act, through data‑sharing protocols, merger due‑diligence considerations, infrastructure investments, internal governance structures and, finally, the strategic advantages of Europe’s cohesive regulatory framework. Internet] CNIL.

Pharmaceutical Companies

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

ID Stewardship

JANUARY 13, 2025

In this article an infectious diseases pharmacist discusses five interesting things to know about sulopenem (Orlynvah). In this article I will go intofive interesting things about solupenem. 2024 Nov 2:S1198-743X(24)00507- X. Chicago, IL: Iterum Therapeutics; 2024. Authored by: Tina Zheng, Pharm.D., Hosp Pharm.

Packaging

PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Washington, DC, USA - June 24, 2022: The symbol of the U.S.

Vaccines

PharmaVoice

JULY 31, 2025

Published July 31, 2025 Meagan Parrish Lead Editor post share post print email license Incoming Novo Nordisk CEO, Maziar Mike Doustdar Permission granted by Novo Nordisk Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback.

Diabetes

Pharma Manufacturing

JULY 14, 2025

Out of 202 Complete Response Letters issued between 2020 and 2024, 150 involved quality/manufacturing issues, according to the regulator’s newly released documents.

Documentation

PharmaVoice

JULY 14, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?

Pharmaceutical Companies

PharmaVoice

JULY 7, 2025

Published July 7, 2025 Amy Baxter Staff Reporter post share post print email license stock via Getty Images Listen to the article 6 min This audio is auto-generated. Estimates vary for how many patients with either obesity or diabetes stop using the drugs, but one 2024 study pegged the discontinuation between 50% and 75% within a year.

Compounding

Pharmaceutical Commerce

JUNE 17, 2025

In this article, we’ll explore the limitations of traditional HTA; the ways AI can enhance HTA methodologies; AI applications in HTA; its integration with existing frameworks; its role in value-based pricing and real-world evidence (RWE) generation; and the limitations of AI in HTA. Haub School of Business.

Insurance Coverage and Processing

PharmaTech

JUNE 19, 2025

link] Recent Videos Related Content FDA Voucher Program Provides Shorter Drug Application Review Time Susan Haigney June 18th 2025 Article The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time. link] Thomas, F. PharmTech.com.

Dosage

Express Pharma

APRIL 27, 2025

In an article published here ten days back, I provided a detailed account of a most worrying case where counterfeiters succeeded in acquiring batch-specific serial numbers of Sun Pharmas anti-epileptic drug Levipil 500, which were then embedded into QR codes on fake packages. The fourth batch (not shown) was manufactured in November 2024.

Packaging

PharmaVoice

JUNE 6, 2025

Published June 6, 2025 Michael Gibney Senior Editor & Writer post share post print email license Permission granted by Daiichi Sankyo Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback.

Chemotherapy

Pharma Manufacturing

JUNE 17, 2025

Magazine ENEWS SUBSCRIBE WEBINARS PODCASTS EBOOKS ABOUT US Edit submissions Media kit Innovation Awards Articles Flow state: The evolving shape of continuous manufacturing June 17, 2025 While the pharmaceutical industry has been slow to adopt continuous manufacturing, it appears to be gaining momentum.

Dosage

Pharma Marketing Network

JULY 26, 2025

This article explores the key Pharma Marketing Challenges that define 2025—and what pharma brands must do to stay relevant, effective, and compliant. According to Edelman’s 2024 Trust Barometer, the healthcare sector saw only modest improvements in public trust. That’s the crossroads pharma marketing faces today.

HIPAA

Pharmacy Times

AUGUST 6, 2025

According to the CDC, national kindergarten vaccination coverage dropped to 93% in the 2023-2024 school year, down from prepandemic levels of approximately 95%. October 2, 2024. August 2, 2024. Vaccine coverage and exemptions among kindergarteners. Accessed July 16, 2025. McKee C, Bohannon K. J Pediatr Pharmacol Ther.2016;21(2):104-109.

Vaccines

PharmaVoice

JULY 8, 2025

Published July 8, 2025 By Kelly Bilodeau post share post print email license Stock via Getty Images Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. It’s human instinct to want to destroy cancer as fast as possible. Cancer is this bug.

Immunity

pharmaphorum

JULY 24, 2025

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmacy Times

JULY 16, 2025

14,15 Lung Cancer Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post Progression Tarlatamab has shown promising efficacy in relapsed SCLC based on the initial single-arm trial findings, leading to an FDA approval in 2024, but challenges with administration have limited its widespread adoption.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 12, 2025

Published May 6, 2024. Published March 22, 2024. Published June 18, 2024. Last Updated October 2, 2024. Published October 21, 2024. Accessed August 11, 2025. Gallagher A. V116 Demonstrates Positive Immunogenicity for 21 Pneumococcal Serotypes. Pharmacy Times. Accessed August 11, 2025. Gallagher A. Pharmacy Times.

Immunity

PharmaVoice

JUNE 9, 2025

Published June 9, 2025 Amy Baxter Staff Reporter post share post print email license Permission granted by Roche Listen to the article 6 min This audio is auto-generated. Even Novo and Lilly have faced troubles this year as the market moves past the “peak hype” of 2024, according to a recent report from IQVIA.

Biosimilars

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmacy Times

AUGUST 11, 2025

December 15, 2024. Updated September 10, 2024. Community-based Care Transitions Program. Centers for Medicare & Medicaid Services. Accessed July 7, 2025. Medication reconciliation. Patient Safety Network. Accessed July 7, 2025. Nowosielski B. Pharmacists’ expertise can improve patient outcomes in transitions of care. Drug Topics.

Medication Therapy Management (MTM)

Pharmacy Times

AUGUST 1, 2025

April 9, 2024. Here’s How. Author(s): Debra Patt, MD, PhD, MBA , Jeff Hunnicutt Key Takeaways PBMs, initially designed to reduce costs, now inflate drug prices and dominate the market, impacting patient access to affordable medications. REFERENCES Fein AJ. Drug Channels. Accessed July 23, 2025. News release. Federal Trade Commission.

Pharmacy Technician

Express Pharma

JUNE 19, 2025

By 2024, more than 750 Indian facilities were registered with the U.S. In FY 2024–25, India’s pharmaceutical exports exceeded USD 30.3 Furthermore, FDA Warning Letters issued between 2020 and 2024 show a disproportionately higher number of citations for sterile product manufacturers. Why this article?

Documentation

Pharmacy Times

AUGUST 7, 2025

Published May 6, 2024. MMWR Recommendations and Reports. 2022;71(3):1-95. doi:10.15585/mmwr.rr7103a1 4. Guideline Recommendations and Guiding Principles. Overdose Prevention. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Labelling

Pharmaceutical Commerce

JUNE 18, 2025

9, 2024—seven weeks before the one-year stabilization period was set to end. UCB to Invest $5 Billion into US Production Plant Nicholas Saraceno, Editor June 16th 2025 Article The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city to be named at a later date.

Drug Pricing

Pharmacy Times

JUNE 27, 2025

5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. June 21, 2024. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL. Hemasphere.

Pharmacy Technician

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. 2 From October 2024 to March 2025, the CDC reported at least 37 million influenza infections, 480,000 hospitalizations, and 21,000 deaths.

Pharmacy Technician

Drug Channels

DECEMBER 12, 2024

Click here to see the original post from September 2024. Below, I review the latest data on 2024 trends and compare them to the pre-pandemic figures. Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Time for DCIs annual update on the channels for provider-administered drugs.

Specialty Pharmacies

Pharmacy Times

AUGUST 13, 2025

Arexvy was the first RSV vaccine approved by the FDA in May 2023 for adults aged 60 years and older, followed by Abrysvo, also in May 2023, and mRESVIA in May 2024; however, their indications have been updated since their initial approval. August 30, 2024. Human Vaccines & Immunotherapeutics , 21 (1). RSV in Adults. News release.

Vaccines